Understanding and Relieving of Neuropathic Disorders in the Long COVID

Infect Disord Drug Targets. 2023;23(4):e270223214061. doi: 10.2174/1871526523666230227113205.
No abstract available

Publication types

  • Editorial

MeSH terms

  • COVID-19*
  • Humans
  • Post-Acute COVID-19 Syndrome*